Westlake Chemical Partners (WLKP)
(Delayed Data from NYSE)
$22.08 USD
-0.13 (-0.59%)
Updated Sep 10, 2024 04:00 PM ET
5-Strong Sell of 5 5
A Value A Growth F Momentum A VGM
Income Statements
Fiscal Year end for Westlake Chemical Partners LP falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,191 | 1,593 | 1,215 | 967 | 1,092 |
Cost Of Goods | 803 | 1,216 | 773 | 588 | 712 |
Gross Profit | 387 | 377 | 442 | 379 | 379 |
Selling & Adminstrative & Depr. & Amort Expenses | 30 | 30 | 31 | 26 | 29 |
Income After Depreciation & Amortization | 358 | 348 | 411 | 353 | 350 |
Non-Operating Income | 4 | 2 | 0 | 1 | 3 |
Interest Expense | 27 | 13 | 9 | 12 | 20 |
Pretax Income | 335 | 336 | 402 | 342 | 334 |
Income Taxes | 1 | 1 | 1 | 1 | 1 |
Minority Interest | 280 | 271 | 319 | 275 | 272 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 335 | 335 | 401 | 341 | 333 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 54 | 64 | 83 | 66 | 61 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 468 | 469 | 520 | 456 | 457 |
Depreciation & Amortization (Cash Flow) | 110 | 121 | 109 | 103 | 107 |
Income After Depreciation & Amortization | 358 | 348 | 411 | 353 | 350 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 35.25 | 35.26 | 35.28 | 35.20 | 34.45 |
Diluted EPS Before Non-Recurring Items | 1.54 | 1.82 | 2.34 | 1.88 | 1.77 |
Diluted Net EPS (GAAP) | 1.54 | 1.82 | 2.34 | 1.88 | 1.77 |
Fiscal Year end for Westlake Chemical Partners LP falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 284.17 | 284.67 | 297.27 | 321.66 | 264.18 |
Cost Of Goods | 182.94 | 182.49 | 196.59 | 228.68 | 176.46 |
Gross Profit | 101.23 | 102.18 | 100.68 | 92.98 | 87.72 |
SG&A, R&D, and Dept/Amort Expenses | 7.61 | 7.08 | 7.87 | 6.74 | 7.23 |
Income After SG&A, R&D, and Dept/Amort Expenses | 93.62 | 95.10 | 92.81 | 86.24 | 80.49 |
Non-Operating Income | 1.26 | 1.33 | 1.08 | 1.27 | 1.06 |
Interest Expense | 6.65 | 6.58 | 6.63 | 6.44 | 6.12 |
Pretax Income | 88.23 | 89.86 | 87.26 | 81.08 | 75.44 |
Income Taxes | 0.21 | 0.21 | 0.21 | 0.22 | 0.17 |
Minority Interest | 73.60 | 74.81 | 72.76 | 67.65 | 63.38 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 88.03 | 89.65 | 87.06 | 80.85 | 75.26 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 14.43 | 14.83 | 14.30 | 13.21 | 11.89 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 35.19 | 35.30 | 34.88 | 35.69 | 34.96 |
Diluted EPS Before Non-Recurring Items | 0.41 | 0.42 | 0.41 | 0.37 | 0.34 |
Diluted Net EPS (GAAP) | 0.41 | 0.42 | 0.41 | 0.37 | 0.34 |